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Summary 
Myelin allows for fast and efficient axonal conduction, but much remains to be determined about 
the mechanisms that regulate myelin formation. To investigate the genetic basis of myelination, 
we carried out a genetic screen using zebrafish. Here we show that the lysosomal Gprotein 
RagA is essential for CNS myelination. In rraga-/- mutant oligodendrocytes, target genes of the 
lysosomal transcription factor Tfeb are upregulated, consistent with previous evidence that 
RagA represses Tfeb activity.  Loss of Tfeb function is sufficient to restore myelination in RagA 
mutants, indicating that hyperactive Tfeb represses myelination. Conversely, tfeb-/- single 
mutants exhibit ectopic myelin, further indicating that Tfeb represses myelination during 
development.  In a mouse model of de- and remyelination, TFEB expression is increased in 
oligodendrocytes, but the protein is localized to the cytoplasm, and hence inactive, especially 
during remyelination.  These results define essential regulators of myelination and may advance 
approaches to therapeutic remyelination.  
 
Introduction 
Myelin, the membranous sheath that insulates axons in vertebrates, is essential for both 
rapid conduction of action potentials and for metabolic and trophic support of axons 
(Funfschilling et al., 2012; Sherman and Brophy, 2005; Simons and Nave, 2016).   
Oligodendrocytes mature from oligodendrocyte precursor cells (OPCs), some of which 
differentiate during development, while others persist into adulthood (Emery, 2010).  Adult 
OPCs can differentiate into myelinating oligodendrocytes to form new myelin in the adult brain, 
which occurs in response to motor learning in the healthy brain and also in diseases such as 
Multiple Sclerosis (MS) (Almeida and Lyons, 2017; Bengtsson et al., 2005; McKenzie et al., 
2014; Münzel et al., 2013). MS results from inflammatory disruption of myelin in the CNS. 
Demyelination and irreversible axon loss in MS lead to impaired vision, loss of coordination, 
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muscle weakness, fatigue, and cognitive impairment (Browne et al., 2014; Dutta and Trapp, 
2011; Franklin and Ffrench-Constant, 2008; Münzel et al., 2013). Despite the importance of 
myelination in the healthy and diseased CNS, the molecular mechanisms that control 
oligodendrocyte development are only partly understood. 
 
Lysosomes, long recognized as degradative organelles in the cell, are emerging as 
important signaling hubs that integrate nutrient availability with specialized cellular functions 
(Appelqvist et al., 2013; Ferguson, 2015; Saftig and Haas, 2016; Settembre and Ballabio, 2014; 
Settembre et al., 2013). Biochemical studies have defined the roles of several essential 
lysosomal proteins in the context of nutrient sensing and regulation of metabolic pathways 
(Efeyan et al., 2015). For example, in the presence of amino acids, GTP-bound heterodimeric 
Rag-GTPases (RagA or B bound to Rag C or D) recruit mTORC1 to the lysosomal membrane, 
where its then activated to induce protein synthesis and cell growth (Kim et al., 2008; Sancak et 
al., 2008; Shaw, 2008). This process requires the guanine nucleotide exchange factor (GEF) 
activity of the Ragulator complex, encoded by the lamtor genes (Bar-Peled et al., 2012; Sancak 
et al., 2010). Additionally, RagA regulates the activity of Transcription Factor EB (TFEB), which 
controls lysosomal biogenesis and autophagy (Sardiello, 2016; Sardiello et al., 2009; Settembre 
et al., 2011).  When nutrients are available and lysosomal activity is sufficient, RagA recruits 
TFEB to the lysosome, where it is phosphorylated and inactivated.  When the cell is starved or 
when lysosomal activity is disrupted or insufficient, TFEB is dephosphorylated, allowing it to 
enter the nucleus and activate target genes that control lysosome biogenesis, autophagy, and 
lipid catabolism (Martina and Puertollano, 2013; Napolitano and Ballabio, 2016).  In addition to 
controlling lysosomal activity in phagocytic cells (Shen et al., 2016), RagA and RagB also 
function in cardiomyocytes, underscoring the important roles of the lysosomes in diverse cell 
types (Kim et al., 2014). Moreover, TFEB activation promotes clearing of intracellular debris in 
laboratory models of neurodegenerative diseases such as Huntington’s disease (Appelqvist et 
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al., 2013; Martini-Stoica et al., 2016; Williams et al., 2008), but the roles of RagA and TFEB in 
other aspects of CNS development and disease remain unexplored. 
 
Starting with a forward genetic screen in zebrafish, we define essential functions for several key 
lysosomal signaling molecules in myelination. We show that mutations in rraga or the Ragulator 
component lamtor4 result in reduced CNS myelination. We find that TFEB target genes are 
significantly upregulated in myelinating glia of rraga-/- mutants. Consistent with the hypothesis 
that increased TFEB activity blocks myelination in rraga-/- mutants, elimination of tfeb activity 
rescues myelination in rraga-/- mutants. Additionally, in tfeb-/- mutants we observe ectopic 
myelination in the dorsal spinal cord and ectopic expression of myelin basic protein (MBP) in the 
hindbrain.  Moreover, transient overexpression of a nonphosphorylatable Tfeb construct 
represses mbp mRNA expression, further demonstrating that tfeb represses myelination in the 
developing CNS. We also explored the possibility that TFEB may be regulated during 
remyelination after injury.  We find that localization of TFEB to the cytoplasm of 
oligodendrocytes (where it is inactive as a transcription factor) increases during remyelination in 
a mouse model of focal demyelination. Together, our results reveal essential roles for RagA and 
TFEB in regulating myelination, and suggest that manipulation of TFEB or its downstream 
effectors may represent a new avenue for improving therapeutic remyelination in MS. 
 
 
Results 
The Rag-Ragulator complex is essential for CNS myelination 
In a forward genetic screen using zebrafish, we identified rraga and lamtor4, which encode 
RagA and the Ragulator component Lamtor4, respectively, as genes essential for microglia 
development (Shen et al., 2016). To examine myelination in zebrafish carrying mutations in 
these genes, we analyzed the expression of the myelin markers myelin basic protein (mbp) and 
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proteolipid protein (plp1b) by in situ hybridization (ISH). Homozygous rraga-/- mutants exhibited 
reduced mbp mRNA expression in the central nervous system (CNS) (Figure 1A, white arrows), 
whereas mbp expression in the peripheral nervous system (PNS) was normal (Figure 1A, black 
arrows). Similarly, expression of plp1b mRNA was reduced in rraga-/- homozygous mutants 
(Figure 1B). As described previously (Shen et al., 2016), lamtor4-/- homozygous mutants and 
rraga-/- mutants have very similar phenotypes (Figure S1).  
 
Previous biochemical studies have provided evidence that the Rag-Ragulator complex recruits 
mTORC1 to lysosomes, where it is activated in response to amino acids (Napolitano and 
Ballabio, 2016; Sancak et al., 2010). To determine if reduced mTORC1 activity might cause the 
reduction of myelin in rraga-/- mutants, we compared the phenotypes of rraga-/- and mtor-/- 
mutants using the previously identified mtorxu015 insertional allele (Ding et al., 2011). This 
analysis revealed important differences in the rraga-/- and mtor-/- mutant phenotypes. mtor -/-
mutants exhibited a slight delay in overall development and partial reduction in mbp expression 
both in the CNS and PNS (Figure 1C), whereas rraga-/- mutants exhibit a strong, CNS-specific 
reduction of mbp expression (Figure 1A). In addition, treatment of wildtype zebrafish with 
Torin1, a potent and specific inhibitor of mTOR signaling (Thoreen et al., 2012), led to an overall 
developmental delay and slight reduction of mbp expression in both CNS and PNS, similar to 
mtor-/- mutants (Figure S2). Collectively, these experiments show that mtor-/- mutants express 
nearly normal levels of mbp in the CNS, in contrast to the strong and specific reduction of mbp 
in the CNS that is evident in rraga-/- mutants. These phenotypic studies indicate that the Rag-
Ragulator complex has a role in oligodendrocyte myelination that is independent of mTOR. 
 
 
RagA acts autonomously in oligodendrocytes 
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To determine the cellular basis of RagA function in CNS myelination, we transiently expressed 
full-length wildtype rraga mRNA in rraga-/- mutants under the control of different cell type-
specific regulatory sequences. Expression of mbp was rescued in rraga-/- mutants when the 
wildtype rraga gene was expressed in oligodendrocytes (claudinK promoter), but not when 
expressed in neurons or microglia (huC or mpeg promoter, respectively) (Figure 1D,E).  
Previous transcriptomic studies in mammals show that Rraga expression increases in 
myelinating oligodendrocytes, consistent with its cell autonomous function in myelination 
(Marques et al., 2016). Combined with our previous analysis of microglia (Shen et al., 2016), 
these results indicate that RagA has independent and cell autonomous functions in 
oligodendrocytes and microglia. 
 
 
Myelin is reduced but oligodendrocytes are present in rraga-/- mutants 
 
To determine if myelin ultrastructure is disrupted in rraga-/- mutants, we performed transmission 
electron microscopy on transverse sections of the ventral spinal cord in wildtype and rraga-/- 
mutant zebrafish.  At 5 dpf, wildtype siblings had approximately 4-fold more myelinated axons 
than rraga-/- mutants (Figure 2A). At 9 dpf, the number of myelinated axons increased in 
wildtype siblings, whereas no additional myelinated axons were detected in rraga-/- mutants 
(Figure 2B). rraga-/- mutants and their wildtype siblings had similar numbers of myelinated axons 
in the posterior lateral line nerve, which is a component of the PNS (Figure 2C). This 
ultrastructural analysis of rraga-/- mutants confirms that RagA is essential for myelination in the 
developing CNS, but not the PNS. 
 
To determine if CNS myelin is reduced because rraga-/- mutants have fewer oligodendrocytes 
than wildtype, we examined the expression of olig2. Expression of olig2 mRNA, which marks 
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motor neurons and cells of the oligodendrocyte lineage (Ravanelli and Appel, 2015; Zhou and 
Anderson, 2002), was normal in rraga-/- mutants at 3 dpf, as detected by in situ hybridization 
(Figure S3A).  Similarly, analysis of the transgenic reporter Tg(olig2:GFP) (Shin et al., 2003) at 
4 dpf showed that the number and distribution of olig2-GFP expressing cells were comparable 
between rraga-/- mutants and their wildtype siblings (Figure 2D).  
 
To examine later stages of oligodendrocyte development, we used the transgenic reporter line 
Tg(claudink:EGFP ), which expresses GFP in mature oligodendrocytes and Schwann cells 
(myelinating glia of the PNS) (Münzel et al., 2012). The claudink:EGFP reporter is expressed in 
the CNS of rraga-/- mutants, but at lower levels than in wildtype siblings (Figure 2E, Figure S3B). 
In agreement with the olig2 marker analysis, oligodendrocyte cell bodies are visible in both 
rraga-/- mutants and their wildtype siblings (arrows), but in rraga-/- mutants the myelinating 
processes that normally extend along the axonal tracts are severely reduced (Figure 2E, 
arrowheads). These studies indicate that cells of the oligodendrocyte lineage are present in 
rraga-/- mutants, and that the onset of myelination is disrupted. 
 
Transcriptomic analysis reveals upregulation of lysosomal genes and TFEB targets in 
myelinating glia of rraga-/- mutants 
 
To investigate the pathways that are disrupted in myelinating glia of RagA mutants, we 
conducted RNA-sequencing of FACS-sorted Tg(claudinK:GFP) expressing cells from wildtype 
and rraga-/- mutant larvae at 5 dpf. claudink is expressed in oligodendrocytes and Schwann cells 
(Münzel et al., 2012), but because myelin appears to be normal in the PNS of rraga-/- mutants 
(Figure 1A, 2E), differences detected in Tg(claudink:GFP) expressing cells are likely to reflect 
changes in the oligodendrocyte transcriptome. Comparison of wildtype and rraga-/- mutant 
samples revealed 343 genes significantly upregulated in Tg(claudink:GFP) expressing cells of 
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rraga-/- mutants (>2.5X , p<0.01) and 298 significantly downregulated genes (<2.5X, p<0.01) 
(Figure 3A, Tables S1, S2 and S3). Consistent with the reduction of myelination in the CNS of 
rraga-/- mutants, expression of myelin genes including plp1b and myelin protein zero (mpz) was 
significantly reduced (Figure 3A). Also consistent with our observation that PNS myelin is 
normal in rraga-/- mutants, the key regulators of Schwann cell myelination egr2b and pou3f1 are 
expressed at similar levels in wildtype and rraga-/- mutants. 
 
Functional annotation with PANTHER (Mi et al., 2013, 2017) revealed that genes associated 
with lysosomal activities were significantly enriched within the upregulated genes in rraga-/- 
mutant myelinating glia (GO term: cellular component, Table S1). TFEB directly activates the 
expression of more than 400 genes involved in lysosomal biogenesis, autophagy, mitophagy, 
lipid catabolism and lysosomal biogenesis (Medina et al., 2011; Napolitano and Ballabio, 2016; 
Nezich et al., 2015; Palmieri et al., 2011; Settembre et al., 2011). We compared our lists of 
genes differentially expressed in myelinating glia of rraga-/- mutants (upregulated and 
downregulated) to a previously compiled list of TFEB target genes (Palmieri et al., 2011). 17 
previously defined TFEB target genes were upregulated in myelinating glia of rraga-/- mutants, 
including ctsa, ctsba, atp6ap1b, agtrap, hexb and sqstm1 (Figure 3A and Table S3). Similar 
analysis identified 4 TFEB target genes in the downregulated dataset, namely hoxc13a, 
prkag2b, naglu and comtd (Figure 3A  and TableS3). 
 
 
Confirming and extending our analysis of TFEB target gene expression in myelinating glia, we 
performed quantitative RT-PCR on total RNA from wildtype and rraga-/- mutants. Our analysis of 
21 well established TFEB target genes (Palmieri et al., 2011) confirmed that ctsba, ctsa and 
sqstm1 are significantly upregulated in rraga-/- mutants, and identified 9 more TFEB target 
genes upregulated in whole-animal RNA samples, including gla, hexa,  lamp1a, psap, clcn7, 
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gba and neu (Figure S4A). Taken together these experiments provide evidence that TFEB 
target genes are upregulated in oligodendrocytes of rraga-/- mutants, consistent with previous 
reports demonstrating that RagA represses TFEB in other cell types (Martina and Puertollano, 
2013).  
 
The Rag-Ragulator complex promotes CNS myelination by repressing TFEB 
 
Recent work has shown that active Rag GTPases repress TFEB by binding and recruiting it to 
lysosomes, where TFEB is phosphorylated and inactivated (Martina and Puertollano, 2013).  
Previous studies show that both Rraga and Tfeb are expressed in oligodendrocytes and that 
their expression increases as myelination progresses, consistent with the possibility that RagA 
antagonizes TFEB activity in oligodendrocytes (Lister et al., 2011; Marques et al., 2016).  These 
previous studies, together with the upregulation of TFEB target genes in myelinating glia of 
rraga-/- mutants, led us to investigate whether aberrantly increased TFEB activity blocks 
myelination in rraga-/- mutant oligodendrocytes. This hypothesis predicts that TFEB represses 
myelination and that inactivation of TFEB would rescue CNS myelination in rraga-/- mutants 
(Figure 3B). 
 
We used Crispr–Cas9 to generate mutations near the 5’end of the tfeb coding sequence and 
establish two new alleles of tfeb: tfebst120 and tfebst121 (Figure 3C). As expected for a loss of 
function allele, quantitative RT-PCR analysis showed that some known TFEB target genes are 
indeed downregulated in tfeb transheterozygous mutants (tfeb st120/st121, henceforth indicated as 
tfeb-/- mutant), including hexa, gba, gla, neu1, psap and sqstm1 (Figure S4B). Strikingly, 
expression of mbp and plp1b mRNA was partially restored in rraga-/- mutants heterozygous for 
tfeb+/- mutations, and mbp was restored to wildtype levels in rraga-/-;tfeb-/- double mutants 
(Figure 3D, Figure S5). Furthermore, in the ventral spinal cord, electron microscopy analysis 
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revealed that rraga-/-; tfeb-/- double mutants have many more myelinated axons than rraga-/- 
single mutants (36 and 8, respectively) (Figure 3E,F).  Our analysis of myelin gene expression 
and myelin ultrastructure in these mutants indicates that TFEB is hyperactive in 
oligodendrocytes of rraga-/- mutants and that inhibiting TFEB activity can rescue myelination in 
rraga-/- mutants.  
 
To test the hypothesis that TFEB represses myelination in the developing CNS, we examined 
expression of mbp mRNA, myelin ultrastructure, and MBP protein in tfeb-/- mutant larvae. At 5 
dpf mbp and plp1b mRNA levels are indistinguishable in tfeb-/- mutants and their wildtype 
siblings (Figure 3D and Figure S5). To determine if tfeb-/- mutants have normal myelin, we next 
examined CNS ultrastructure by transmission electron microscopy. While our analysis revealed 
no statistical difference in the number of myelinated axons in the ventral spinal cord of tfeb-/- 
mutants and their wildtype siblings (ventral: 54 vs. 51, Figure 4A), there was a significant 
increase in the number of myelinated axons in the dorsal spinal cord of tfeb-/- mutants (dorsal: 
48 vs. 32, Figure 4B). To determine if oligodendrocytes are altered in the brain of tfeb-/- mutants, 
we examined the expression and localization of MBP protein in the hindbrain of 8 dpf tfeb-/- 
mutants and siblings.  MBP protein is normally localized in oligodendrocyte processes and 
largely excluded from the cell body (Figure 4C). In the hindbrain of 8 dpf tfeb-/- mutants, 
however, we observed MBP ectopically expressed in a region of the hindbrain that normally 
contains oligodendrocyte cell bodies with little or no MBP (Figure 4 C,D, red arrows). Our 
analysis of tfeb-/- and rraga-/-;tfeb-/- double mutants indicates that TFEB represses myelination in 
CNS, and that RagA is essential to prevent hyperactivity of TFEB in oligodendrocytes. 
 
Our hypothesis that TFEB activity represses myelination in the CNS predicts that 
overexpression of a constitutively active (i.e. non-phosphorylatable) form of TFEB will repress 
myelination (Puertollano et al., 2018; Sardiello et al., 2009; Settembre et al., 2011). To 
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determine if overexpression of constitutively active Tfeb represses myelination we transiently 
expressed a phosphorylation-null Tfeb mutant (Tfeb PN: S3A+S149A+S221A+S484A+S486A), 
under the control of the claudink promoter. Transient transgenesis results in high variability of 
transgene expression both within and between individuals. To select individuals with a higher 
rate of transgenesis, the transgenesis vector contained a cmlc2:GFP reporter, which allowed 
transgenic animals to be identified by GFP expression in the heart. At 4 dpf, injected fish were 
sorted into GFP+ or GFP- groups (transgenic and weakly or non transgenic, respectively), and 
mbp expression was monitored by in situ hybridization. As predicted, transient overexpression 
of phosphorylation-null Tfeb resulted in a decrease in mbp mRNA expression levels in some of 
the injected fish (Phospho-null 12%, 6/50 fish) (Figure 4E).  Together, our data provide evidence 
that RagA functions to promote myelination by repressing TFEB, which in turn inhibits 
myelination in the CNS. 
 
Levels of cytoplasmic TFEB increase in remyelinating lesions in mouse 
 
Our data indicate that Tfeb represses myelination during development. We next explored 
whether TFEB is altered after injury during the process of remyelination. We used an adult 
mouse model of demyelination and remyelination, where focal demyelination is induced by 
stereotactic injection of the demyelinating agent L-α-lysophosphatidylcholine (LPC) into the 
corpus callosum (Boyd et al., 2013) (Figure 5A). Remyelination relies on the recruitment of 
oligodendrocyte precursor cells (OPCs) to demyelinated lesions and their subsequent 
differentiation into myelin-forming oligodendrocytes. In this model, oligodendrocyte 
differentiation begins at 10 days post injection (dpi), early remyelination is present at 14 days 
dpi and is complete by 28 days dpi (Boyd et al., 2013). Immunohistochemical analysis of control 
adult mouse corpus callosum (either uninjected or injected with PBS) showed that the majority 
of CC1+ oligodendrocytes have low levels of cytoplasmic TFEB expression, but there were a 
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small number of oligodendrocytes with high TFEB expression (Figure 5B, C, D). TFEB 
expression was almost exclusively localized to the cytoplasm of CC1+ oligodendrocytes, with 
nuclear TFEB localization rarely observed (approximately 1/cell per optical frame) (Figure 5B, C, 
D). During the early stages of remyelination (14 dpi), we observed a significant increase in the 
number of oligodendrocytes with high cytoplasmic TFEB expression in the lesion and perilesion 
areas (Figure 5E and E’). The number of oligodendrocytes with high cytoplasmic expression of 
TFEB dropped significantly at the late remyelination stage (28 dpi), when the lesion is mostly 
remyelinated (Figure 5F and F’).   
 
 
Discussion 
TFEB represses myelination 
Our experiments demonstrate that TFEB inhibits myelination. TFEB loss-of-function mutations 
cause ectopic myelination in the dorsal spinal cord and ectopic expression of Myelin Basic 
Protein in the hindbrain. Conversely, rraga-/- mutants have increased TFEB activity, which in 
turn blocks myelination. Furthermore, expression of constitutively active TFEB also inhibits mbp 
expression.  Consistent with previous biochemical studies (Martina and Puertollano, 2013), our 
analyses showed that RagA and TFEB have opposing functions in CNS myelination in vivo. In 
striking contrast to rraga-/- single mutants, rraga-/-; tfeb-/- double mutants have apparently normal 
levels of mbp expression. Expression of mbp is also partially rescued in rraga-/-; tfeb+/- mutants, 
indicating that myelination is very sensitive to the level of tfeb function.  Thus, the analysis of 
both loss and gain of TFEB activity defines TFEB as a repressor of myelination.  
 
Oligodendrocytes are present in rraga-/- mutants and are competent to myelinate if tfeb activity 
is partially (haploinsufficiency) or fully eliminated, indicating that TFEB blocks mbp expression in 
pre-myelinating oligodendrocytes.  Previous studies have defined a brief developmental window 
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(~5 hours in zebrafish) during which an oligodendrocyte can initiate new myelin segments 
(Czopka et al., 2013).  After this critical period, new myelin segments are not initiated, although 
previously established segments are maintained and expanded.  It is possible that TFEB closes 
the critical period, such that myelination is greatly curtailed by hyperactive TFEB in rraga-/- 
mutants. 
 
There are many possible mechanisms by which TFEB might repress myelination. TFEB is a 
transcriptional regulatory protein, raising the possibility that TFEB might directly repress myelin 
gene expression in oligodendrocytes.  There are, however, no reported TFEB binding sites in 
the vicinity of the myelin basic protein gene, suggesting that TFEB represses myelination 
indirectly.  In other cell types, TFEB activates hundreds of target genes that regulate diverse 
lysosome-related processes, including lysosome biogenesis and exocytosis, autophagy, and 
lipid catabolism (Napolitano and Ballabio, 2016).  Our analysis indicates that TFEB activates at 
least some of these previously known target genes in oligodendrocytes as well.  It is likely that 
inappropriately increased activity of one or more TFEB-regulated processes disrupts 
myelination in oligodendrocytes.  For example, TFEB hyperactivity might disrupt the trafficking 
of endolysosomal organelles to the membrane or synthesis of lipids critical for the formation of 
the membranous myelin sheath, which could in turn impede myelination. 
 
RagA and other regulators of TFEB in myelination 
Our mutational analysis demonstrates that the lysosomal genes rraga and lamtor4 are essential 
for myelination in the CNS, but not the PNS. RagA and Lamtor4 are components of the Rag-
Ragulator complex, which recruits TFEB to the lysosome, where it is phosphorylated and 
inactivated (Efeyan et al., 2015).  mTOR, which is recruited to the lysosome by RagA-
dependent and -independent mechanisms, is one kinase that can phosphorylate and inactivate 
TFEB (Martina et al., 2012; Roczniak-Ferguson et al., 2012; Settembre et al., 2011, 2012) .  If 
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mTOR inactivated TFEB in the context of myelination, we would expect mtor-/- mutants to have 
hyperactive TFEB and a phenotype similar to rraga-/- mutants. Our data, however, suggest that 
mTOR is not the only kinase that can repress TFEB activity in oligodendrocytes, because mtor-/- 
mutants have much more mbp expression in oligodendrocytes than rraga-/- mutants.  Previous 
studies show that the kinases GSKβ3, ERK2, AKT, and PKCβ can also phosphorylate TFEB, 
and some combination of these likely controls TFEB activity during myelination (Li et al., 2016; 
Martina and Puertollano, 2013; Medina et al., 2015; Palmieri et al., 2017; Puertollano et al., 
2018; Roczniak-Ferguson et al., 2012; Settembre et al., 2011).   
 
TFEB during remyelination 
Our analysis indicates that TFEB represses myelination during development, raising the 
question of its role during remyelination. In control mouse white matter, TFEB is mainly detected 
at low levels in the cytoplasm of mature oligodendrocytes and is rarely localized in the nucleus. 
TFEB protein levels increase in the cytoplasm of mature oligodendrocytes during remyelination, 
suggesting that it is predominantly inactive and thus permitting the remyelination process. After 
remyelination is complete, TFEB expression declined to near normal levels. It may seem 
somewhat paradoxical that levels of TFEB - a repressor of myelination - increase in 
remyelinating cells. One possibility is that TFEB, as a component of the integrated stress 
response (Martina et al., 2016), is more highly expressed due to the stress of the injury, and is 
subsequently inactivated by cytoplasmic localization when remyelination commences. RagA 
and kinases that phosphorylate TFEB (GSKβ3, ERK2, AKT, PKCβ, mTORC) may be essential 
to retain TFEB in the cytoplasm during remyelination. Animals with increased TFEB function, 
e.g rraga-/- mutants or Tfeb phosphorylation-null transgenic animals, will be valuable models in 
which to better characterize the role of TFEB and its regulators in the context of remyelination.  
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Understanding the nature of the signals that regulate TFEB expression and localization in 
oligodendrocytes of the healthy and diseased brain will be critical to understand its function in 
oligodendrocyte development, myelination, and remyelination.  Elucidating the target genes and 
processes downstream of TFEB that are inhibitory to myelination may define additional 
regulators of myelination and myelin repair, which in turn may suggest strategies for therapeutic 
remyelination.  
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Figure 1. rraga is essential for CNS myelination and acts autonomously in 
oligodendrocytes 
 (A-E) Analysis of mbp or plp1b mRNA expression at 5 dpf by whole mount in situ hybridization. 
(A) Compared to their wildtype siblings, rraga-/- mutants show reduced mbp expression in the 
CNS (white arrows), whereas mbp expression in the PNS is normal (black arrows). (B) 
Expression of plp1b is also reduced in rraga-/- mutants. See also Figure S1. (C) mtor-/- mutants 
are developmentally delayed and have a small reduction in mbp mRNA expression levels in the 
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CNS and PNS. See also Figure S2. (D)  Quantification of rescue of mbp expression in rraga-/-
mutants following expression of wildtype rraga under the control of the claudink, mpeg 
(expressed in macrophages) or huc promoter (expressed in neurons). (E) Whole mount in situ 
hybridization analysis of mbp mRNA expression in 5 dpf rraga-/- mutants following expression of 
wild type rraga under the control of different tissue-specific promoters. mbp mRNA expression is 
partially or fully rescued only when wild type rraga is expressed in oligodendrocytes (claudinK 
promoter).  All panels show dorsal views, with anterior to the top. Genotypes of all animals 
shown were determined by PCR after imaging. Scale bar = 50 µm. 
 
Figure 2. CNS myelination is severely reduced in rraga mutants although 
oligodendrocytes are present  
(A,B) TEM images of transverse sections of the ventral spinal cord (CNS) at 5 dpf (A) and 9 dpf 
(B) show fewer myelinated axons in rraga-/- mutants (middle panel) compared to wildtype 
siblings (left panel). Quantification of the number of myelinated axons in the ventral spinal cord 
at 5 dpf and 9 dpf is shown on the right; bar graph depicts average values and standard error; 
individual measurements are also shown.  (C) TEM images of transverse sections of the 
posterior lateral line nerve (pLLn) at 9 dpf show normal myelination in rraga-/- mutants (middle 
panel) compared to the wildtype sibling (left panel). Quantification of the number of myelinated 
axons in the pLLn at 9 dpf is shown on the right; bar graph depicts average values and standard 
error; individual measurements are also shown. Red arrows indicate unmyelinated axons and 
yellow arrows indicate myelinated axons. 3 wildtype and 3 rraga-/- mutants were analyzed. Scale 
bar = 1µm. (*** p <0.001, Student t-test, two-tailed). (D) Lateral view of 4 dpf Tg(olig2:EGFP) 
larvae showing comparable numbers of olig2-positive cells in both wildtype (top panel) and 
rraga-/- mutant (lower panel); panel shows anterior to the left and dorsal up. See also Figure S2. 
(E) Dorsal view of 4 dpf Tg(cldnk:EGFP) embryos showing presence of oligodendrocytes 
(arrows) in both wildtype (top panel) and rraga-/-
 
mutants (lower panel), but reduced expression 
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of GFP along myelinated axonal tracts (arrowheads). Panel shows anterior to the left and dorsal 
up. Genotypes of all animals shown were determined by PCR after imaging.  
 
Figure 3. RagA promotes CNS myelination by repressing TFEB 
(A) Volcano plot depicting the genes differentially expressed (p<0.01) in rraga-/- mutants relative 
to wildtype animals. Among the significantly downregulated genes (<2.5X) are mpz and plp1b 
(purple), which at this stage are characteristic of CNS myelin. Expression levels of 17 previously 
defined targets of TFEB (red) are upregulated (>2.5) in rraga-/- mutants. Inset graph depicts 
previously known TFEB targets (red) upregulated in rraga-/- mutants. See also Table S1-S3 (B) 
Diagrammatic representation of the hypothesis that RagA promotes myelination by repressing 
TFEB, which inhibits CNS myelination. (C) Diagrammatic representation of TFEB protein and of 
predicted truncated proteins encoded by tfebst120 and tfebst121 mutant alleles. (D) Expression of 
mbp mRNA, as detected by whole mount in situ hybridization, is reduced in CNS of rraga-/- 
mutants, but is restored in rraga-/-;tfeb-/- double mutants. rraga-/-;tfeb-/- double mutants and tfeb-/- 
mutants are indistinguishable from wildtype larvae. See also Figure S5. Scale bar = 50 µm. (E) 
TEM images of transverse sections of the ventral spinal cord (CNS) at 9 dpf show that 
myelination is restored in rraga-/-;tfeb-/- double mutants. Red arrows indicate unmyelinated axons 
and yellow arrows indicate myelinated axons. Scale bar = 1µm.  (F) Quantification of the 
number of myelinated axons per hemi ventral spinal cord at 9 dpf is shown on the right; graph 
depicts average values and standard deviation; individual measurements are also shown. 3 
individuals of each genotype were analyzed. (Statistical analysis: Pairwise comparisons using 
one-way ANOVA, Tukey post-hoc test significant interaction p<0.0001 ****, p <0.001***). 
 
Figure 4. TFEB represses myelination in the CNS 
(A,B) TEM images of transverse sections of the spinal cord at 9 dpf show an increased number 
of myelinated axons in the dorsal spinal cord of tfeb mutants. Quantification of the number of 
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myelinated axons per ventral (A) or dorsal (B) hemi spinal cord is shown on the right. Graph 
depicts average values and standard deviation; individual measurements are also shown. 
Yellow arrows indicate myelinated axons. Scale bar =5 µm. (Statistical analysis: Two-tailed 
unpaired t-test with Welch’s correction). 3 wildtype and 4 tfeb-/- mutant animals were analyzed. 
(C) Dorsal view of the hindbrain of 8 dpf larvae shows robust expression of MBP protein in 
myelinating oligodendrocyte processes in wild type and tfeb-/- mutants, and ectopic expression 
of MBP protein in tfeb-/- mutant cell bodies (red arrows). Scale bar = 50 µm.  (D) Quantification 
of the number of ectopic MBP positive cells in tfeb-/- mutants (tfeb-/-, n=11) and siblings (n=13 for 
wildtype and tfeb+/- heterozygotes) (Pairwise comparisons using one-way ANOVA, Tukey post-
hoc test significant interaction p<0.0001 ****); bars represent standard deviation values. 
Individual values are also depicted. Genotypes of all animals shown were determined by PCR 
after imaging. (E) Whole mount in situ hybridization analysis of mbp mRNA expression in 5 dpf 
fish following transgenic expression of phosphorylation-null Tfeb (Tfeb NP) under the control of 
claudink promoter. mbp mRNA expression is reduced in some fish overexpressing the 
construct. (F) Quantification of the percentage of fish with reduced mbp mRNA expression. 
(Statistical analysis: Fisher’s exact test, two tailed, p< 0.01 **). 
 
Figure 5. Remyelinating lesions in mouse show increased levels of cytoplasmic TFEB. 
(A) Low power image of LPC injected corpus callosum, 14 dpi stained for MBP (red), CC1 
(green) and Hoechst (blue). The area of the lesion is outlined with dashed white line, and the 
perilesion area is marked. (B) TFEB is mostly found in the cytoplasm in mature 
oligodendrocytes of the rodent corpus callosum, both in those expressing low levels (white 
asterisk) and high levels (red asterisk).  Rarely both cytoplasmic and nuclear TFEB expression 
is detected (white arrow). (C) A few mature, CC1 (green) expressing oligodendrocytes of the 
adult, normal, rodent corpus callosum show high level expression of TFEB (red) in the 
cytoplasm. Most express low levels of TFEB in the cytoplasm (C’, TFEB white). (D) PBS-
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injected control corpus callosum 14 dpi. CC1+ oligodendrocytes display a similar TFEB 
expression profile to untreated controls (C,C’) (E) LPC-injected tissue 14 dpi (early 
remyelination time point). An increased number of CC1+ oligodendrocytes with high cytoplasmic 
TFEB expression appear in the corpus callosum (E,E’). (F) LPC-injected tissue 28 dpi (late 
remyelination time point). Very few CC1+ oligodendrocytes have high cytoplasmic TFEB 
expression (F,F’). (G) Quantification of the percentage of CC1+TFEB+ cells with high 
cytoplasmic TFEB levels in the corpus callosum after LPC focal lesion induction. Graph depicts 
average value and SEM. Individuals values are also represented. A marked increase is 
observed during early remyelination in lesion and perilesion areas (14 dpi) that significantly 
drops at later remyelination stages. Statistical analysis: non parametric ANOVA (Kruskal-Wallis 
test) with Dunn’s post hoc test. Total P value 0.0456 and significance between 14dpi and 28 dpi. 
 
 
 
STAR Methods 
Contact for reagent and resource sharing 
Further information and requests for resources and reagents should be directed to and will be fulfilled by 
the Lead Contact, William S Talbot (william.talbot@stanford.edu). 
 
Experimental model and subject details 
Zebrafish 
Zebrafish embryos, larvae and adults were produced, grown and maintained according to 
standard protocols approved by the Stanford University Institutional Animal Care and Use 
Committee. Ethical approval was obtained from the Stanford University Institutional Animal Care 
and Use Committee. To obtain embryos and larvae used in experiments, adults 3-18 months 
were crossed. Adult density was maintained at 5-10 fish/L, with a 14hr light/ 10nr dark cycle and 
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fish were fed twice daily. Water temperature was maintained at 28ºC. Embryos and larvae were 
treated with 0.003% 1-phenyl-2-thiourea (PTU) to inhibit pigmentation, and they were 
anesthetized with 0.016% (w/v) Tricaine prior to experimental procedures.    
Published strains used in this study include: wildtype TL, mtorxu015 (Ding et al., 2011), 
Tg(olig2:GFP) (Shin et al., 2003), Tg(cldnk:GFP) (Münzel et al., 2012), rragast77 and lamtor4 
st99/st99 (Shen et al., 2016). Details of the construction of the new strains generated in this study 
are described below.  
 
Mouse 
Mice were housed and used according to standard UK Home Office regulations, under project 
license 60/ 4524 awarded to AW. 12-14 week old C57BL/6 male mice were used for all 
experiments. Experimental details are described below.  
 
Method details 
In situ hybridization 
In situ hybridization on embryos and larvae was performed using standard methods (Thisse et 
al., 2004). Briefly, embryos were fixed overnight in 4% paraformaldehyde, dehydrated for at 
least 2 hr in 100% methanol, rehydrated in PBS, permeabilized with proteinase K, and 
incubated overnight with antisense riboprobes at 65°C. The probe was detected with an anti-
digoxigenin antibody conjugated to alkaline phosphatase (11093274910, Sigma-Aldrich). 
Images were captured using the Zeiss AxioCam HRc camera with the AxioVision software. 
Probes for mbp and olig2 were previously described (Lyons et al., 2009; Park et al., 2002). A 
700 bp fragment of plp1b gene was amplified from 5 dpf whole larvae cDNA using the following 
primers: 5’- AACAGCCGTGGTTGTGTAAAGC-3’ and 5’-TATGTTGGCCAGTGCATTTCCAC-3’. 
The resulting fragment was cloned into the pCRII vector using Dual promoter TA cloning Kit 
(K207020, Invitrogen) to generate a riboprobe for plp1b. The construct was linearized with SpeI 
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and antisense probe was transcribed with T7 RNA polymerase (AM2085, Ambion). For each 
genetic cross, at least 3 independent clutches were analyzed. For each genotype a minimum of 
10 total fish were analyzed.   
 
Whole-mount immunofluorescence 
For MBP immunofluorescence 8 dpf zebrafish larvae were fixed in 4%PFA/PBS, overnight at 
4ºC. Larval brains were dissected and incubated with rabbit anti-MBP (Lyons et al., 2005). Anti- 
rabbit Alexa Fluor568 was used at 1/1000 (A-11011, ThermoFisher).  Embryos were mounted in 
DAPI Fluoromount-G (SouthernBiotech). Transgenic zebrafish embryos were mounted in 1.5% 
low melting point agarose in distilled water. Images were captured using a Zeiss LSM 5 Pascal 
or Zeiss LSM 7 microscope. Objectives used were Plan-Neofluar 10× (numerical aperture 0.30) 
and 20× (numerical aperture 0.75). All fish were genotyped after imaging and analysis.   
 
Crispr/Cas9 targeting 
sgRNAs were designed using CHOPCHOP (https://chopchop.rc.fas.harvard.edu/, (Labun et al., 
2016; Montague et al., 2014), transcribed with T7 polymerase (E2040S, New England Biolabs) 
and purified using mirVana miRNA isolation kit (AM1560, Ambion). Cas9 protein (Macrolab, 
Berkeley, http://qb3.berkeley.edu/macrolab/cas9-nls-purified-protein/) was injected together with 
300 ng sgRNA into 1-cell stage embryos, and the embryos were genotyped after analysis to 
detect lesions. sgRNAs used were: TFEB (5’-GGTGCACTGATGGCTGGCGT-3’).  
 
tfebst120 and tfebst121 mutant alleles 
tfeb mutants were generated by raising embryos injected with sgRNA 5’-
GGTGCACTGATGGCTGGCGT-3’. Two mutants were isolated and tested. tfebst120 contains a 
5 bp deletion which results in a change in reading frame after amino acid 45 and a premature 
stop codon after amino acid 61 compared to 491 amino acids for the WT protein. tfebst121 
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contains a 8 bp deletion which results in a change in reading frame after amino acid 46 and a 
premature stop codon after amino acid 60. tfeb mutants were genotyped using the primers 5′- 
GCTCATGCGGGACCAAATGC -3′ and 5′- GGTCACACTAACAAATGTGG -3′. PCR products 
were digested with Cac8I (R0579, New England Biolabs). Mutant (233+83 bp) and WT (213bp + 
83 +25 bp) bands were distinguished by running the digested PCR product on a 3% agarose 
gel. tfebst120/st120, tfebst121/st121 and tfebst120/st121 transheterozygotes all displayed equal 
phenotypes. All experiments were performed in transheterozygous fish. 
 
FAC sorting and RNA sequencing 
WT and rraga-/- mutant Tg(cldnk:GFP) larvae at 5 dpf were distinguished by neutral red staining 
and pooled for RNA isolation (Shen et al., 2016), in two independent experiments. Dissociation 
of embryos was carried out as previously described (Manoli and Driever, 2012) and GFP-
positive cells were isolated at the Stanford Shared FACS Facility. RNA was isolated using the 
Qiagen RNeasy micro kit (74004, Qiagen) and provided to the Stanford Functional Genomics 
Facility. Libraries were prepared and sequenced using the Illumina NextSeq Mid platform.  
 
qRT-PCR 
Total RNA was extracted from larvae at 5 dpf with the RNAeasy kit (QIAGEN). cDNA was 
synthesized using iScript supermix (Biorad). qPCR was performed with SsoAdvancedTM 
Universal SYBR Green Supermix (Bio-Rad) on the Bio-Rad CFX384 Real-Time PCR Detection 
System. All experiments were done in biological and technical triplicates. Transcript levels were 
normalized to ef1-alpha (primers were previously reported (Shen et al., 2016; Shiau et al., 
2013).  Relative mRNA levels were calculated using ΔΔCT. 
 
 
RNA Seq analysis  
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Over 7.5M paired end reads were obtained for each sample. These reads were mapped to the 
zebrafish reference genome (NCBI) using CLC Genomics Workbench 11.0 
(http://www.clcbio.com/products/clc-genomics-workbench/) and over 90% of the sequenced 
fragments mapped to annotated genes. Differential expression analysis was performed by 
comparing the mapped WT and rraga-/- mutant reads, while controlling for the two independent 
experiments. Annotation was performed using the Danio rerio annotation file downloaded from 
Gene Ontology Consortium (http://www.geneontology.org/page/download-annotations). Raw 
and analyzed data were deposited with GEO, GSE119332. 
 
Gene Ontology Enrichment 
The list of 343 genes upregulated (p<0.01, >2,5X) in myelinating glia of rraga-/- was queried in 
PANTHER11 using gene ontology term cellular component (Mi et al., 2013, 2017). 
 
Identification of Tfeb targets in genes upregulated in rraga-/- mutants 
Significantly upregulated (p<0.01, >2.5X) and downregulated genes (p<0.01, <2.5X) in rraga-/- 
mutants were mapped to human orthologues using the Ensemble Biomart feature and 
compared to the list of TFEB targets (471 genes, (Palmieri et al., 2011)). 15 zebrafish genes 
orthologous to human Tfeb target genes were identified in the upregulated dataset, and 4 were 
identified in the downregulated dataset. Manual curation identified two additional upregulated 
genes with human TFEB target orthologues. Processing and analysis of gene lists was 
performed using Python.  
 
 
Expression constructs and transient injections 
The coding sequence of rraga was cloned from 5 dpf embryonic cDNA pool and directionally 
inserted into pCR8/GW/TOPO vector (Invitrogen). Synthetic DNA encoding sequence of Tfeb 
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(ENSDART00000182200.1) and Tfeb phosphorylation-null mutant was obtained from 
Integrated DNA Technologies (IDT) and subcloned into pCR8/GW by Gibson assembly (New 
England Biolabs). For transient transgenesis, rraga, tfeb and tfeb phospho-null sequences were 
subcloned into pDestTol2CG2 by multisite gateway. The tissue-specific regulatory sequences 
used have been reported elsewhere (Shen et al., 2016; Shiau et al., 2013). Tissue-specific 
transgenes were transiently expressed by co-injecting 12-25 pg of Tol2 plasmids described 
above and 100-200 pg of Tol2 transposase mRNA in 1 cell embryos.  
 
Transmission Electron Microscopy 
TEM was performed as described previously (Lyons et al., 2008). Briefly, decapitated embryos 
were fixed in 2% glutaraldehyde and 4% paraformaldehyde in 0.1 M sodium cacodylate buffer 
(pH 7.4). The posterior portion of the larvae was used to isolate DNA for genotyping. For 
secondary fixation, samples were fixed in 2% osmium tetraoxide, 0.1 M imidazole in 0.1 M 
sodium cacodylate (pH7.4), stained with saturated uranyl acetate, and dehydrated in ethanol 
and acetone. Fixation and dehydration were accelerated using the PELCO 3470 Multirange 
Laboratory Microwave System (Pelco) at 15°C. Samples were then incubated in 50% Epon/50% 
acetone overnight, followed by 100% Epon for 4 hr at room temperature. Samples were then 
embedded in 100% Epon and baked for 48 hr at 60°C. Blocks were sectioned using a Leica 
Ultramicrotome. Thick sections (500–1,000 μm) for toluidine blue staining were collected on 
glass slides, stained at 60°C for 5 s, and imaged with the Leica DM 2000 microscope using the 
Leica DFC290 HD camera and Leica Application Suite software. After the desired region of the 
spinal cord was reached, we collected ultrathin sections for TEM analysis on copper grids, and 
we stained them with uranyl acetate and Sato’s lead stain (1% lead citrate, 1% lead acetate, 
and 1% lead nitrate). Sections were imaged on a JEOL JEM-1400 transmission electron 
microscope. 
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Drug Treatment 
For Torin1 treatment, WT fish were incubated in 1 μM Torin1 (4247, Tocris Bioscience) in 
embryo water with PTU from 24 hpf to 5 dpf; fresh embryo medium, PTU and Torin1 were 
replaced daily.  
 
 
LPC-induced demyelinating lesions in rodents 
Focal demyelination was induced via stereotactic injection of L-α-Lysophosphatidylcholine (LPC,  
L4129, Sigma-Aldrich) into the corpus callosum of 12-14 week old C57BL/6 male mice (n=2-3 per 
time point). Anesthetized animals received 2μL of 1% LPC through a burr hole in the skull and at 
stereotactic coordinates 1.2 mm posterior, 0.5 mm lateral, 1.4 mm deep to the bregma over 4 
minutes using a 30 gauge needle attached to a Hamilton syringe and driven by a Nano pump (KD 
Scientific Inc., Holliston, MA). The needle was additionally left on site for additional 4 minutes to 
avoid backflow. Similar stereotactic injection of PBS was followed to create a surgical control 
(PBS control). LPC causes reversible focal demyelination without axonal loss. The time course of 
de- and remyelination is well established and reproducible with demyelinated lesions appearing 
as early as 3 days post injection (3dpi). Two time points with early (14 dpi) and late (28 dpi) 
remyelination were analyzed. Mice were subsequently perfused with 4% PFA, the brain tissue 
was harvested, cryoprotected in 30% sucrose and frozen embedded in OCT compound.  
 
Immunohistochemistry of mouse tissue and quantification. 
10 μm thick cryosections were briefly washed in PBS and microwaved for 10 minutes in Vector 
Unmasking Solution for antigen retrieval (H-3300, Vector) before blocking with 10% normal 
horse serum, 0.3% Triton-X in 1xPBS for 1 hr at RT. Sections were then incubated with primary 
antibodies in the same solution overnight at 4oC in a humidified chamber. Following washes in 
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PBS, the cryosections were incubated with Alexa Fluor secondary antibodies (Thermo Fischer 
Scientific, 1:1000) for 1 ½ hrs at room temperature and counterstained with Hoechst for the 
visualization of the nuclei. Primary antibodies used: rabbit polyclonal anti-TFEB (Bethyl 
laboratories inc, A303-673A, 1:1000), mouse IgG anti-APC (CC1, OP80, Merck-Millipore, 1:500) 
and rat IgG2a anti-Myelin Basic Protein (clone 12, AbD Serotec, 1:300). All slides were mounted 
using mowiol mounting medium (475904, MERCK- Millipore) and imaged using Leica TCS SP8 
confocal microscopy. From each section 3-5 random fields (145.31μm x 145.31μm each) were 
obtained. 2 sections were analyzed per animal. Total number of CC1/TFEB double positive 
oligodendrocytes was counted in lesion and perilesion areas (CC1+TFEB+/mm2). For the same 
area, the number of CC1/TFEB double positive cells with high cytoplasmic TFEB levels was 
also counted (CC1+ TFEB+ cytoplasmic high/mm2). Values for each sample were averaged, and data 
are depicted as mean percentage of CC1+ TFEB+ cytoplasmic high/CC1+TFEB+ cells. 
 
 
Quantification and Statistical analysis 
Sample sizes were chosen based on previous publications and are indicated in each figure 
and/or figure legend. No animal or sample was excluded from the analysis unless the animal 
died during the procedure. Except for electron microscopy samples, zebrafish larvae were only 
genotyped after image acquisition and analysis. EM samples were blinded before counts of 
myelinated axons numbers were performed. The experiments were not randomized. Sample 
sizes, statistical test and P values are indicated in the figures or figure legends. Statistical 
significance was assigned at P < 0.05. Statistical tests were performed using GraphPad Prism 
6 or Prism 7 software. 
 
Table S1. Related to Figure 3. Genes significantly upregulated in FAC-sorted cldnk:GFP 
positive cells of rraga-/- mutants 
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Table S2. Related to Figure 3. Genes significantly downregulated in FAC-sorted 
cldnk:GFP positive cells of rraga-/- mutants 
KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
rabbit anti-MBP (Lyons et al., 2005) NA 
Anti-Digoxigenin-AP, Fab fragments Sigma-Aldrich Cat#11093274910 
monoclonal mouse IgG2B anti-APC MERCK-Millipore Clone#CC1, OP80 
monoclonal IgG2A anti-Myelin Proteolipid Protein MERCK-Millipore clone PLPC1, 
MAB388 
polyclonal rabbit IgG anti -TFEB Bethyl laboratories A303-673A 
Chemicals, Peptides, and Recombinant Proteins 
Torin1 Tocris Bioscience Cat#4247 
Recombinant Cas9-NLS protein Macrolab, Berkeley 
 
http://qb3.berkeley.e
du/macrolab/cas9-
nls-purified-protein/ 
Deposited Data 
Raw and analyzed data RNAseq This publication GEO: GSE119332 
   
Experimental Models: Organisms/Strains 
Zebrafish: mtorxu015  Ding et al., 2011 N/A 
Zebrafish: Tg(olig2:GFP) Shin et al., 2003 N/A 
Zebrafish: Tg(cldnk:GFP) Münzel et al., 2012 N/A 
Zebrafish: tfebst120 This publication N/A 
Zebrafish: tfebst121 This publication N/A 
Zebrafish: rragast77 Shen et al., 2016 N/A 
   
Oligonucleotides 
plp1b riboprobe  
Forward: AACAGCCGTGGTTGTGTAAAGC 
Reverse: TATGTTGGCCAGTGCATTTCCAC 
This publication N/A 
st120/st121 genotyping primer  
Forward: GCTCATGCGGGACCAAATGC 
Reverse: GGTCACACTAACAAATGTGG 
This publication N/A 
st77 genotyping primer  
Forward: GGTACACAAGATGGACCTGGTT 
Reverse: GATAATTGAGGCAGATGAAGTCTT 
Shen et al., 2016 N/A 
   
atg9b-F GGCACCATATCAAGAACCTCG 
atg9b-R CCACAAACAGGAATTGCACAAG 
This publication  
clcn7-F TCCACGTTTCCCTCCTATTC 
clcn7-R AGGAACAGTGTATGGCGTTG 
This publication  
ctsa-F ATCAGTGGAGCAAAGCACAG 
ctsa-R GACCAGCGGGTTATTGAGAT 
This publication  
ctsba-F TGTGATCTCAGCCCTTTCAG 
ctsba-R TATGTCCAGCCGTCCAAGTA 
This publication  
ctsd-F AGGCCTATTGGCAGATTCAC 
ctsd-R GTCCACAATGGCTTCACATC 
This publication  
ef1a-F AGGACATCCGTCGTGGTAAT 
ef1a-R AGAGATCTGCACCAGGGTGGTT 
This publication  
gba-F TCAGCAGACCAGCCTAGAAA 
gba-R ACCGTTTGATCCCAGACTTC 
This publication  
Key Resource Table
gla-F TTCGCAAGACCTGTAACCAC 
gla-R CATGTCAGGGTCATTCCATC 
This publication  
hexa-F GACCCTTCCTTTCCGTATCA 
hexa-R CCTGGCATGTTCAATCACTC 
This publication  
lamp1a-F  GACGAGACGACCAACCTGAC 
lamp1a-R  CTGCCTCAAACACAACGCTC 
This publication  
lamp1b-F TGAACTACTTGGTGGGAACG 
lamp1b-R ATCTCCCTTGACACCGAAAG 
This publication  
mcoln1b-F ACACGTTCGACATAGACCCTC 
mcoln1b-R TACCAACTTCTGAAAATTAAGGGTG 
This publication  
neu1-F ATGGGAAGTCATGGGAGAAG 
neu1-F TCCTCAGCAGAACCTCCTTT 
This publication  
psap-F CAGCAGCTCATGTCTATGGAACAG 
psap-R AGCAGGGATGGATTTGGCAGG 
This publication  
scpep1-F ATACAGCAGCAAAGGCAGTG 
scpep1-R TGTCATGGACCAAAGGTCAG 
This publication  
uvrag-F ACCGGAGGAAGAACAGTTTG 
uvrag-R CACACCTCAGAATCCCAATG 
This publication  
vps11-F GCACATCGACGACAATAACC 
vps11-R TCGTCTTCCTCAATCTGCTG 
This publication  
vps18-F ATGAACTGCCTGTCCAGTTG 
vps18-R ATATCGCCTCCTTGAAGTGG 
This publication  
vps8-F TGTCGGAGTCTTGTTTCTGC 
vps8-R TGGCTCATCCTCATCTTCAG 
This publication  
wipi1-F CAGATGGCTGGTCAGAGAAA 
wipi1-R TGAATAGCTGCCCATCAGAG 
This publication  
wipi2-F ACTTGGACGGGATACTTTGG 
wipi2-R AGCGCAGATGTTCTTGTGTC 
This publication  
 
Recombinant DNA 
Plasmid: claudink:Tfeb PN:polyA  This publication  
   
Software and Algorithms 
GraphPad Prism GraphPad Software RRID:SCR_002798; 
URL: http://www.gra
phpad.com/ 
CLC Genomics Workbench 11.0 QiagenBioinformatics RRID:SCR_011853; 
URL: http://www.clcb
io.com/products/clc-
genomics-
workbench/ 
   
 
A B
C D
WT
WT mtor
WT
m
bp
, 5
dp
f
pl
p1
b,
 5
dp
f
m
bp
, 5
dp
f
m
bp
, 5
dp
f
WT rraga
cldnk::rraga mpeg::rraga huc::rraga
full rescue
9/42
partial rescue
20/42
Pe
rc
en
ta
ge
 re
sc
ue 10080
60
40
20
0
cld
nk:
:rra
ga
mp
eg:
:rra
ga
hu
c::r
rag
a
E
42208N=
full rescue
partial rescue
no rescue
rraga -/- rraga -/-
-/-
-/-
Figure 1
 5
dp
f
A WT
B
C
 9
dp
f
 9
dp
f
Tg (olig2:GFP) Tg (claudink:EGFP)
W
T
W
T
4dpf 4dpf
CNS CNS
CNS CNS
PNS PNS
D E
Sib (n=3) Mut (n=3)
0
40
80
120
   p=0.0001; ***
Number of myelinated axons
in the ventral spinal cord (9dpf)
Sib (n=3) Mut (n=3)
0
40
80
120
   p=0.0001; ***
Sib (n=3) Mut (n=3)
0
5
10
15
   p=0.3739; n.s.
Number of myelinated axons
in each pLLn (9dpf)
Number of myelinated axons
in the ventral spinal cord (5dpf)
rraga -/-
rr
ag
a
-/-
rr
ag
a
-/-
Figure 2
Wildtype
Gln AD bHLH Zip Pro
493
tfebst120 tfebst121
Gln
45 61 46
Gln
60
 m
bp
, 5
dp
f
WT rraga -/-
WT
 9
dp
f
M M
-/-
r ra
ga
tfe
b
- /-
0
20
40
60
80
# 
m
ye
lin
at
ed
 a
xo
ns
 p
er
he
m
i v
en
tr
al
 s
pi
na
l c
or
d
-/-
r ra
ga
# myelinated axons 
** **
** *
** **
A
B
D
E
C
AxonRagA Tfeb
TfebRagA Axon
; tfeb+/-rraga -/- ; tfeb-/-rraga -/- tfeb -/-
rraga -/- ; tfeb-/-rraga -/-
RagA Tfeb Axon
F
W
T
Lo
g 1
0 P
-v
al
ue
0
5
10
0 10-10
sqstm1
amdhd2
cst14a.2 atp6v1ab
cst14b.1
flcn
hexb
hoxb7a
vps33a
megf9
tpp1ifi30
ctsa
agtrapatp6ap1b
atp6v0e1
ctsba
Log2 fold change
Lo
g 1
0 P
-v
al
ue
0
2
4
6
1
Log2 fold change
2 3 4
mpz
plp1b
Figure 3
AWT tfebst120/st121
GFP-
MM
WT tfeb -/-
 m
bp
, 5
dp
f
D
or
sa
l
 V
en
tra
l
0
20
40
60
# 
m
ye
lin
at
ed
 a
xo
ns
 p
er
he
m
i v
en
tr
al
 s
pi
na
l c
or
d
t feb -/-WT
ns
0
20
40
60
80
# 
m
ye
lin
at
ed
 a
xo
ns
 p
er
he
m
i d
or
sa
l s
pi
na
l c
or
d
B
C D
E
GFP+
69/69
Normal
cldnk::Tfeb PN injected
0%
20%
40%
60%
80%
100%
120%
GFP +
Normal
Reduced 
expression
-
Tfeb PN
Pe
rc
en
ta
ge
 o
f f
is
h 
w
ith
 re
du
ce
d
 m
bp
 m
R
N
A 
ex
pr
es
si
on
N= 69 50
F
**
P=0.0046
tfeb -/-
tfeb -/-WT
*
P=0.0446
0
1 0
2 0
3 0
# 
of
 M
B
P+
 o
lig
od
en
dr
oc
yt
e 
ce
ll 
bo
di
es
t feb -/-WT t feb +/-
ns
****
****
GFP+
44/50
Normal
6/50
Reduced
 M
BP
, 8
dp
f
Figure 4
Untreated PBS 
Control 
14dpi 28dpi
0
5
10
15
20 P=0.0456
%
 o
f C
C
1+
 T
FE
B
+ 
ce
lls
 w
ith
 h
ig
h 
cy
to
pl
as
m
ic
 T
FE
B
Lesion
MBP
Perilesion
CC1 Hoechst TFEB Hoechst
TF
EB
C
C
1
H
oe
ch
st
TF
EB
H
oe
ch
st
Untreated PBS control 14dpi 28dpi
A B
C
C’
G *
**
Cytoplasmic/Nuclear
Low
High
D
D’
E
E’
F
F’
Figure 5
1 
 
Figure S1 
 
 
 
 
 
 
Figure S1. Related to Figure 1. lamtor4 is essential for CNS myelination. 
(A) Analysis of mbp mRNA expression at 5 dpf by whole mount in situ hybridization. Compared 
to their wildtype siblings, lamtor4-/- mutants show reduced mbp expression in the CNS (white 
arrows), whereas mbp expression in the PNS is normal (black arrows). All panels show dorsal 
views, with anterior to the top. Genotypes were determined by PCR after imaging. Scale bar = 
50 µm. 
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Figure S2 
 
 
Figure S2. Related to Figure 1. Torin treated fish are developmentally delayed 
mbp mRNA expression at 5 dpf as detected by whole mount in situ hybridization. Wildtype 
larvae treated with the mTOR signaling pathway inhibitor TORIN1 have delayed developmental 
progression and slightly reduced levels of mbp mRNA both in the CNS and PNS. Genotypes 
were determined by PCR after imaging. Scale bar = 50 µm.  
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Figure S3 
 
 
Figure S3. Related to Figure 2. rraga-/- mutants have normal number of cells expressing 
olig2. 
(A) Analysis of olig2 mRNA expression at 3 dpf by whole mount in situ hybridization. Number of 
olig2 positive cells is similar in rraga-/- mutants and wildtype siblings. 
(B) Dorsal view of 4 dpf Tg(claudinK:GFP) zebrafish larvae shows that rraga-/- mutants express 
claudink:GFP, but at reduced levels. Genotypes were determined by PCR after imaging 
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Figure S4 
 
 
Figure S4. Related to Figure 3. RagA  promotes CNS myelination by repressing TFEB 
(A) Whole animal quantitative RT-PCR analysis reveals overexpression of some TFEB target 
genes in rraga-/- mutants. (B) Whole animal qRT-PCR reveals reduced expression of some 
TFEB target genes in tfeb-/- mutants. Graphs depict average values and standard error of the 
mean (** p <0.01, Student T-test, two-tailed). 
 
 
 
5 
 
Figure S5 
 
 
Figure S5. Related to Figure 3. plp expression is restored in rraga-/-;tfeb-/- double mutants 
Dorsal view of 5 dpf whole mount in situ hybridization to detect plp1b mRNA. Expression of 
plp1b mRNA is nearly absent in rraga-/- mutants, but is restored in rraga-/-;tfeb-/- double mutants. 
By this assay rraga-/-;tfeb-/- double mutants and tfeb-/- mutants  are indistinguishable from 
wildtype larvae.  Expression of mbp is also partly rescued in rraga-/-;tfeb+/- mutants.  Genotypes 
were determined by PCR after imaging. Scale bar = 50 µm 
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Table S3 
 
Table S3. Related to Figure 3. Upregulated or downregulated TFEB target genes in FAC-
sorted cldnk:GFP positive cells of rraga-/- mutants 
 
Upregulated TFEB target genes Downregulated TFEB target genes 
Zebrafish Gene Human Gene Zebrafish Gene Human Gene   
agtrap AGTRAP hoxc13a HOXC13 
amdhd2 AMDHD2 prkag2b PRKAG2 
atp6ap1b ATP6AP1 naglu NAGLU 
atp6v0e1 atp6v0e1 comtd1 COMTD1 
atp6v1ab ATP6V1A   
cst14a.2 CSTB   
cst14b.1 CSTB   
ctsa CTSA   
ctsba CSTB   
flcn FLCN   
hexb HEXB   
hoxb7a HOXB7   
ifi30 IFI30   
megf9 MEGF9   
sqstm1 SQSTM1   
tpp1 TPP1   
vps33a VPS33A  
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